No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Child
-
Dasatinib / therapeutic use*
-
Gene Rearrangement*
-
Humans
-
Male
-
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / genetics
-
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / pathology
-
Prognosis
-
Receptor, Platelet-Derived Growth Factor beta / genetics*
-
Remission Induction
Substances
-
Antineoplastic Agents
-
Receptor, Platelet-Derived Growth Factor beta
-
Dasatinib